MedPath

comparison of therapeutic effect of surfactant injection through tracheal in neonates with respiratory distress syndrome hospitalized in Amir al-momenin Hospital in Semna

Not Applicable
Conditions
Respiratory distress syndrome.
Respiratory distress syndrome of newborn
Registration Number
IRCT2016080825732N8
Lead Sponsor
Semnan University of Medical Sciences, Vice Chancellor for Research and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

premature infants admitted to the neonatal intensive care unit with definitive diagnosis of RDS by pediatrician using clinical symtoms including tachypnea, intercostal retraction, nasal flaring, cyanosis, and hypotension and respiratory arrest. Exclusion criteria: infants with major abnormalities, chromosomal abnormalities, severe asphyxia, and need to Antvbyshn at birth.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of respiratory distress. Timepoint: Before starting study and one hour after Following Prescribing Dosing surfactant. Method of measurement: Based on radiography.;Apgar score. Timepoint: minute one and five Birth. Method of measurement: View Information registered records Filed in the labor.
Secondary Outcome Measures
NameTimeMethod
Severity of respiratory distress. Timepoint: After injecting surfactant. Method of measurement: Based on Picture Radiography.
© Copyright 2025. All Rights Reserved by MedPath